Linked Life Data

21178655

Source:http://linkedlifedata.com/resource/pubmed/id/21178655

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2011-5-18
pubmed:databankReference
pubmed:abstractText
An open-label study evaluated the safety (n = 53) and pharmacokinetics (n = 8) of single-dose therapy with 1500 mg famciclovir (prodrug of penciclovir) for recurrent herpes labialis in adolescents. Mean Cmax, mean AUC0-?, and clearance for penciclovir were 9.37 ?g/mL, 31.8 ?g · h/mL, and 38.2 L/h, respectively, and within the range extrapolated from data in adults. Adverse events were generally mild and transient.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1532-0987
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
525-8
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Safety and pharmacokinetics of a single 1500-mg dose of famciclovir in adolescents with recurrent herpes labialis.
pubmed:affiliation
Department of Pediatrics, University of Kentucky College of Medicine, Louisville, KY, USA. sblock@pol.net
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't